Spectrum Pharmaceuticals has acquired an early-phase anti-CD20 cancer asset from ImmunGene as part of a broader deal. The agreement gives Spectrum an antibody-interferon fusion technology drug ...
Irvine’s Spectrum Pharmaceuticals Inc. is looking to make a name for itself. The company has made moves to jump from generic versions of common drugs to brand-name treatments for cancer. For now, ...
BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the ...
Guidelines for the treatment of healthcare-associated pneumonia recommend the use of broad-spectrum therapy. But based on current evidence, use of broad-spectrum therapy may not be warranted, ...
Stanford Schor Stanford University School of Medicine Division of Infectious Diseases and Geographic Medicine, Department of Medicine Shirit Einav M.D. Division of Infectious Diseases and Geographic ...
Irvine drug maker Spectrum Pharmaceuticals Inc. is raising money. Spectrum said earlier this month that it’s getting $20 million in cash from Par Pharmaceutical Cos. of Woodcliff Lake, N.J., for a ...
It looked at the impact of two types of taxes on different groups of drugs. Firstly, a percentage tax (5% or 20%) on all antibiotics, all broad-spectrum antibiotics, and specific broad-spectrum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback